MariMed files proxy to seek stockholder approval for reverse stock split to pursue U.S. exchange listing

MariMed filed a definitive proxy statement to seek stockholder approval for a reverse stock split aimed at enabling a potential U.S. national exchange listing.Key Highlights:Original SEC Filing: MARIMED INC. [ MRMD ] - 8-K - Sep. 23, 2026This is an AI-powered summary. It may contain inaccuracies. C…